Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
Journal of Medical Virology|September 5, 2024
The effect of recombinant zoster vaccine on patients with chronic obstructive pulmonary diseases: A multi-institutional propensity score-matched cohort studyYa-Wen Tsai, Bin Zhang, Jheng-Yan Wu, et al.
BMC Medicine|September 3, 2024
New-onset obstructive airway disease following COVID-19: a multicenter retrospective cohort studyMin-Hsiang Chuang, Wei Hsu, Ya-Wen Tsai, et al.
BMC Infectious Diseases|April 1, 2025
Outcomes of non-hospitalized patients with COVID-19 versus seasonal influenza during the fall-winter 2022-2023 periodWan-Hsuan Hsu, Bo-Wen Shiau, Ya-Wen Tsai, et al.
Journal of Global Antimicrobial Resistance|March 21, 2023
Clinical efficacy of ertapenem vs. other carbapenems for the treatment of extended-spectrum-β-lactamase-producing Enterobacterales infection: A systematic review and meta-analysisPo-Yu Huang, Chi-Kuei Hsu, Ting-Hui Liu, et al.
Expert Review of Anti-Infective Therapy|November 15, 2023
Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseasesTing-Hui Liu, Jheng-Yan Wu, Po-Yu Huang, et al.
Age and Ageing|November 14, 2023
Real-world data analysis of post-COVID-19 condition risk in older patientsTing-Hui Liu, Po-Yu Huang, Jheng-Yan Wu, et al.
Cells|October 25, 2024
β-Mangostin Alleviates Renal Tubulointerstitial Fibrosis via the TGF-β1/JNK Signaling PathwayPo-Yu Huang, Ying-Hsu Juan, Tung-Wei Hung, et al.
Frontiers in Pharmacology|June 1, 2026
Comparative effectiveness of tirzepatide versus thiazolidinedione in adults with MASLD: a propensity score-matched cohort studyJheng-Yan Wu, Yu-Min Lin, Wan-Hsuan Hsu, et al.
Journal of Medical Virology|May 23, 2023
Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID-19 and substance use disorders based on real-world dataTing-Hui Liu, Po-Yu Huang, Jheng-Yan Wu, et al.
Expert Review of Anti-Infective Therapy|October 18, 2024
Clinical effectiveness of oral antivirals for non-hospitalized adult COVID-19 patients aged 18-60 yearsWan-Hsuan Hsu, Bo-Wen Shiau, Ya-Wen Tsai, et al.
Pageof 15